High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). - Galligioni,E..; Cetto,G..; Nascimben,O..; Buonadonna,A..; Crivellari,D..; Molino,A.. (Eur J Cancer, 1998)